Ironwood Pharmaceuticals, Inc. (IRWD)
NASDAQ: IRWD · Real-Time Price · USD
3.650
+0.150 (4.29%)
At close: Mar 9, 2026, 4:00 PM EDT
3.670
+0.020 (0.55%)
After-hours: Mar 9, 2026, 7:56 PM EDT
Ironwood Pharmaceuticals Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Cash & Equivalents | 215.46 | 88.56 | 92.15 | 656.2 | 620.13 | Upgrade
|
| Cash & Short-Term Investments | 215.46 | 88.56 | 92.15 | 656.2 | 620.13 | Upgrade
|
| Cash Growth | 143.29% | -3.90% | -85.96% | 5.82% | 71.04% | Upgrade
|
| Accounts Receivable | 46.75 | 81.89 | 129.12 | 115.46 | 114.04 | Upgrade
|
| Receivables | 46.75 | 81.89 | 129.12 | 115.46 | 114.04 | Upgrade
|
| Prepaid Expenses | 11.98 | 11.92 | 12.01 | 7.72 | 8.69 | Upgrade
|
| Restricted Cash | - | - | - | 1.25 | 1.25 | Upgrade
|
| Other Current Assets | - | - | - | - | 1.12 | Upgrade
|
| Total Current Assets | 274.18 | 182.37 | 233.29 | 780.63 | 745.23 | Upgrade
|
| Property, Plant & Equipment | 12.75 | 15.52 | 18.17 | 20.31 | 22.93 | Upgrade
|
| Other Intangible Assets | 2.04 | 2.86 | 3.68 | - | - | Upgrade
|
| Long-Term Deferred Tax Assets | 103.43 | 144.23 | 212.32 | 283.66 | 333.29 | Upgrade
|
| Long-Term Deferred Charges | 2.9 | 3.9 | 2.4 | - | - | Upgrade
|
| Other Long-Term Assets | 1.6 | 2.02 | 1.21 | 15.92 | 25.48 | Upgrade
|
| Total Assets | 396.9 | 350.91 | 471.07 | 1,101 | 1,127 | Upgrade
|
| Accounts Payable | 2.9 | 2.13 | 7.83 | 0.48 | 0.94 | Upgrade
|
| Accrued Expenses | 19.18 | 26 | 47.22 | 17.71 | 33.29 | Upgrade
|
| Current Portion of Long-Term Debt | 199.68 | - | 199.56 | - | 116.86 | Upgrade
|
| Current Portion of Leases | 3.25 | 3.19 | 3.13 | 3.07 | 3.13 | Upgrade
|
| Current Income Taxes Payable | 0.93 | 0.52 | 1.24 | 0.66 | - | Upgrade
|
| Current Unearned Revenue | 1.11 | 2.03 | 2.62 | - | - | Upgrade
|
| Other Current Liabilities | 15.18 | 4.98 | 14.5 | 3.61 | 7.49 | Upgrade
|
| Total Current Liabilities | 242.22 | 38.85 | 276.1 | 25.53 | 161.7 | Upgrade
|
| Long-Term Debt | 385 | 583.99 | 498.31 | 396.25 | 337.33 | Upgrade
|
| Long-Term Leases | 9.87 | 12.3 | 14.54 | 16.6 | 18.48 | Upgrade
|
| Long-Term Unearned Revenue | 5.3 | - | - | - | - | Upgrade
|
| Other Long-Term Liabilities | 16.35 | 17.11 | 28.42 | 9.77 | 3.5 | Upgrade
|
| Total Liabilities | 658.74 | 652.24 | 817.37 | 448.14 | 521.02 | Upgrade
|
| Common Stock | 0.16 | 0.16 | 0.16 | 0.15 | 0.16 | Upgrade
|
| Additional Paid-In Capital | 1,413 | 1,395 | 1,355 | 1,349 | 1,543 | Upgrade
|
| Retained Earnings | -1,674 | -1,698 | -1,699 | -696.38 | -937.61 | Upgrade
|
| Comprehensive Income & Other | -1.06 | 0.92 | -3.03 | - | - | Upgrade
|
| Shareholders' Equity | -261.84 | -301.34 | -346.3 | 652.38 | 605.91 | Upgrade
|
| Total Liabilities & Equity | 396.9 | 350.91 | 471.07 | 1,101 | 1,127 | Upgrade
|
| Total Debt | 597.8 | 599.48 | 715.54 | 415.92 | 475.8 | Upgrade
|
| Net Cash (Debt) | -382.35 | -510.92 | -623.38 | 240.29 | 144.33 | Upgrade
|
| Net Cash Growth | - | - | - | 66.49% | - | Upgrade
|
| Net Cash Per Share | -2.35 | -3.19 | -4.01 | 1.29 | 0.88 | Upgrade
|
| Filing Date Shares Outstanding | 163.06 | 161.81 | 156.53 | 154.16 | 159.22 | Upgrade
|
| Total Common Shares Outstanding | 163.06 | 160.21 | 156.35 | 154.03 | 162.04 | Upgrade
|
| Working Capital | 31.96 | 143.52 | -42.81 | 755.1 | 583.53 | Upgrade
|
| Book Value Per Share | -1.61 | -1.88 | -2.21 | 4.24 | 3.74 | Upgrade
|
| Tangible Book Value | -263.88 | -304.2 | -349.98 | 652.38 | 605.91 | Upgrade
|
| Tangible Book Value Per Share | -1.62 | -1.90 | -2.24 | 4.24 | 3.74 | Upgrade
|
| Machinery | 3.76 | 3.89 | 5.42 | 4.23 | 4.13 | Upgrade
|
| Leasehold Improvements | 7.44 | 7.41 | 7.41 | 7.41 | 7.41 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.